Published : Jul-2019
No. of Pages : 46
1.1 List of Tables
1.2 List of Figures
2 Ovarian Cancer: Executive Summary
2.1 Related Reports
2.2 Upcoming Reports
3 Epidemiology
3.1 Disease Background
3.2 Risk Factors
3.3 Global and Historical Trends
3.3.1 7MM Trends in Diagnosed Incidence
3.3.2 7MM Trends in Observed Survival
3.4 Forecast Methodology
3.4.1 Sources
3.4.2 Forecast Assumptions and Methods
3.5 Epidemiological Forecast for Ovarian Cancer (2018-2028)
3.5.1 Diagnosed Incident Cases of Ovarian Cancer
3.5.2 Age-Specific Diagnosed Incidence of Ovarian Cancer
3.5.3 Five-Year Diagnosed Prevalent Cases of Ovarian Cancer
3.5.4 Diagnosed Incident Cases of Ovarian Cancer by Stage at Diagnosis
3.5.5 Diagnosed Incident Cases of Cancer of the Ovary (C56) by Histologic Subtype
3.5.6 Diagnosed Incident Cases of Ovarian Cancer with an Associated Germline BRCA Mutation
3.5.7 Diagnosed Incident Cases of Ovarian Cancer with an Associated Somatic BRCA Mutation
3.5.8 Diagnosed Incident Cases of Ovarian Cancer with HRD
3.5.9 Diagnosed Incident Cases of EOC with FR? Overexpression
3.6 Discussion
3.6.1 Epidemiological Forecast Insight
3.6.2 Limitations of Analysis
3.6.3 Strengths of Analysis
4 Appendix
4.1 Bibliography
4.2 About the Authors
4.2.1 Epidemiologist
4.2.2 Reviewers
4.2.3 Global Director of Therapy Analysis and Epidemiology
4.2.4 Global Head and EVP of Healthcare Operations and Strategy
4.3 About GlobalData
4.4 Contact Us
4.5 Disclaimer
List of Tables
Table 1: Risk Factors for Ovarian Cancer
List of Figures
Figure 1: 7MM, Diagnosed Incident Cases of Ovarian Cancer, Women, Ages ?18 Years, 2018 and 2028, N
Figure 2: Diagnosed Incidence of Ovarian Cancer, 7MM, Women, Ages ?18 Years, 2008-2028, Cases per 100,000 Population
Figure 3: Sources Used and Not Used for Diagnosed Incident Cases of Ovarian Cancer
Figure 4: Sources Used for Diagnosed Incident Cases of Ovarian Cancer by Stage at Diagnosis
Figure 5: Sources Used for Diagnosed Incident Cases of Cancer of the Ovary (C56) by Histologic Subtype
Figure 6: Sources Used for Diagnosed Incident Cases of Ovarian Cancer with an Associated Germline BRCA Mutation
Figure 7: Sources Used for Diagnosed Incident Cases of Ovarian Cancer with an Associated Somatic BRCA Mutation
Figure 8: Sources Used for Diagnosed Incident Cases of Ovarian Cancer with HRD
Figure 9: Sources Used for EOC Cases with FR? Overexpression
Figure 10: Diagnosed Incident Cases of Ovarian Cancer, 7MM, Women, Ages ?18 Years, 2018
Figure 11: Age-Specific Diagnosed Incident Cases of Ovarian Cancer, 7MM, Women, Ages ?18 Years, 2018
Figure 12: Five-Year Diagnosed Prevalent Cases of Ovarian Cancer, 7MM, Women, Ages ?18 Years, 2018, N
Figure 13: Diagnosed Incident Cases of Ovarian Cancer by Stage at Diagnosis, 7MM, Women, Ages ?18 Years, 2018, N
Figure 14: Diagnosed Incident Cases of Cancer of the Ovary (C56) by Histologic Subtype, 7MM, Women, Ages ?18 Years, 2018, N
Figure 15: Diagnosed Incident Cases of Ovarian Cancer with an Associated Germline BRCA Mutation, 7MM, Women, Ages ?18 Years, 2018, N
Figure 16: Diagnosed Incident Cases of Ovarian Cancer with an Associated Somatic BRCA Mutation, 7MM, Women, Ages ?18 Years, 2018, N
Figure 17: Diagnosed Incident Cases of Ovarian Cancer with HRD, 7MM, Women, Ages ?18 Years, 2018, N
Figure 18: Diagnosed Incident Cases of EOC with FR? Overexpression, 7MM, Women, Ages ?18 Years, 2018, N
